Short description
AdvanDx is a biotech company offering molecular vitro diagnostic kits for the identification and prevention of infectious diseases.
Description
AdvanDx is a leading provider of rapid and accurate molecular diagnostic tests for the identification of pathogens causing critical infections in hospitalized patients. Its mission is to help healthcare providers optimize antibiotic therapy earlier in order to improve patient outcomes while limiting unnecessary antibiotic use and reducing hospital costs.
AdvanDx was founded in 2002 and headquartered in Woburn, Massachusetts.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Woburn, Massachusetts, United States, North America
Founded on
January 1, 2002
Exited on
July 14, 2015
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Absolutely Noaccess, Noaccess, Noaccess, Nopepepe
Sign in for full access
Founders
Henrik Stender